Rationale: Global Lung Function Initiative recommends reporting lung function measures as z-score, and a classification of airflow limitation (AL) based on this parameter has recently been proposed.
Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, with rising morbidity and mortality. COPD affects about 328 million people worldwide, and it is the fourth leading cause of death accounting for 4 million deaths every year (1) (2) (3) .
Although it is assumed that a multidimensional approach is required to adequately assess the severity of COPD, and particularly its impact on patients' health status and the risk of future events (4, 5) , airflow limitation is a hallmark of the disease, and spirometry therefore remains the essential test to diagnose and categorize patients with COPD (6) . In fact, the assessment of the severity of airflow limitation forms part of any COPD severity index (5) .
Airflow limitation has been associated with increased all-cause mortality, even with mild impairment (7, 8) . Although impaired lung function cannot itself be the cause of death, it may be a surrogate measure of the biologic effects of cigarette smoking, which leads to other fatal disorders, such as cardiovascular disease and cancer (9) .
Classically, severity of airflow limitation in COPD has been graded by post-bronchodilator FEV 1 , expressed as percent of predicted values. To date, the most widely used cutoff values are those proposed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) initiative (mild, >80%; moderate, 50-79%; severe, 30-49%; and very severe, ,30%) (6) and the American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines (mild, .70%; moderate, 50-69%; severe, 35-49%; and very severe, ,35%) (10) .
However, the use of percent predicted in this way leads to a pronounced agerelated bias (11) . A more valid approach to reporting lung function measures would be to express results as z-score (number of SDs a result is from the mean predicted value). Unlike percent predicted, z-score is free from bias caused by age, height, sex, and ethnic group, and is therefore particularly useful in defining the lower limit of normal (11, 12) . Recently, it has been reported that a new staging system of airflow limitation severity based on z-score for FEV 1 is in close agreement with the ATS/ERS guidelines (13) . However, the usefulness of this new severity classification to predict mortality of patients with COPD is not known.
The objectives of the present study were to evaluate the prognostic capacity of the airflow limitation classifications based on z-score or percent predicted in patients with COPD. Moreover, we have tried to identify the best thresholds for z-score of post-bronchodilator FEV 1 to predict 5-year survival in patients with COPD.
Methods Study Design and Patients
Between April 2004 and December 2008, a total of 2,614 outpatients with COPD were recruited in the context of the Fuenlabrada cohort study. Details are available elsewhere (14) . Briefly, the study included all subjects aged 40 or older with airflow limitation and a clinical diagnosis of COPD treated by general practitioners or pulmonologists in the ninth district of the Madrid Metropolitan Area, Spain.
The diagnosis of COPD was based on the presence of a post-bronchodilator FEV 1 /FVC ratio less than 0.7 and less than lower limit of normal with clinical confirmation in the patient's clinical record (codes 491.xx or 492.xx of the International Classification of Diseases, Ninth Revision, Clinical Modification). Patients previously diagnosed with asthma, cystic fibrosis, interstitial lung disease, pulmonary thromboembolic disease, active tuberculosis, chest wall disease, neuromuscular disorder, malignant tumor, or history of thoracotomy with pulmonary resection were excluded. All included patients were required to be in stable clinical condition, with no respiratory infection in the previous 6 weeks. The study was approved by local ethics committee.
All participants underwent pulmonary function testing during a baseline clinical examination and provided information on smoking history, exacerbations, current treatment, and comorbidities.
Assessment of Airflow Limitation
Spirometries were performed by the same technician with a MasterScreen Body (Jaeger-Viasys, Würtzburg, Germany), following current guidelines (15) . FVC and FEV 1 were automatically selected as the best value of three acceptable, reproducible maneuvers (16) . After baseline evaluation, four separate doses of 100 mg of salbutamol were given by metered-dose inhaler using a spacer, and spirometry was repeated after a 15-minute delay. Only spirometries with quality grades A or B were accepted.
Predicted values and z-scores were calculated for each subject using prediction equations from the Global Lung Function Initiative (12) , through the GLI-2012 Desktop Software for Large Data Sets (published on www.lungfunction.org).
The severity of airway limitation of the patients with COPD was categorized according to the percent predicted or z-score of post-bronchodilator FEV 1 using three staging systems: (1) GOLD criteria: mild (>80% predicted), moderate (50-79%), severe (30-49%), and very severe (,30%) (6); (2) ATS/ERS recommendations: mild (.70% predicted), moderate (50-69%), severe (35-49%), and very severe (,35%) (10); and (3) proposed classification based on z-score (13): mild (z-score, >22), moderate (23 < z-score ,22), severe (24 < z-score ,23), and very severe (z-score ,24).
Follow-up and Outcome Measurements
Patients were treated by their general practitioner or pulmonologist according to current guidelines (16) , and they were checked every 3-6 months during the follow-up period until December 31, 2010. The primary outcome was time to death for all causes. Secondary outcomes were
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ORIGINAL ARTICLE prediction of all-cause short-term (6-12 mo) to mid-term (up to 5 yr) mortality. Vital status was obtained from personal followup of patients or relatives, national registries, or hospital records, yielding no missing information with respect to mortality.
Statistical Analysis
Continuous variables were expressed as mean 6 SD or median (interquartile range), depending on their normal distribution. Categorical variables were reported as absolute numbers and percentages. Comparisons between groups were performed using analysis of variance with Bonferroni post hoc analysis, Student's t test, or chi-square test. Cohen kappa statistic was used to assess the agreement between airflow limitation classifications.
Standard Cox semiparametric proportional hazard models were used to study time-to-death data. To assess the relation between post-bronchodilator FEV 1 as percent predicted or z-score and total mortality without imposing any a priori shape, a penalized splines method was used. This nonparametric regression model was based on the Akaike information criteria in which all models used FEV 1 = 100% predicted or z-score = 0 as the referents (hazard ratio, 1) (17). In addition, optimal thresholds for z-score were determined for maximizing the area under the curve (AUC) after 5 years of follow-up. Initially, the threshold that leads to the Youden index was computed and then, for each of the two resulting subpopulations and with the same criteria, a new threshold was computed.
Finally, the performance of the time-toevent models was measured using the area under incident-cumulative receiver operating characteristic (ROC) AUC for FEV 1% predicted and FEV 1 z-score as discrete variables. The Delong method was used for the calculation of the standard error of the AUC and of the difference between AUCs (18).
A P value of less than 0.05 was considered statistically significant. SPSS (Armonk, NY), MedCalc (Ostend, Belgium), R statistical software version 3.3.1 ("Bug in Your Hair"; Boston, MA), and the R CRAN survival, risksetROC, and pspline packages (R Foundation for Statistical Computing, Vienna, Austria) were used to develop the analysis.
Results
A total of 2,614 patients with COPD were included in the analysis, totaling the experience of 10,322 person-years. Patients had a mean 6 SD age of 64 6 12 years, and 70.9% were male. At study entry, 35.6% of patients were current smokers and 44.5% former smokers. Based on the GOLD classification, 461 patients (17.6%) had Concordance between the classification of airflow limitation based on GOLD criteria and ATS/ERS recommendations was reasonable, whereas classification based on z-score showed little concordance with the other two schemes (see Tables E3-E5 ). In relation to GOLD classification, the stratification system based on z-score showed that 66.3% of patients remained at the same level of severity, whereas 23.7% worsened and 10.0% improved their severity grade.
Kaplan-Meier curves for different classifications of airflow limitation and mortality are displayed in Figure 1 , and hazard ratios between the different cutoffs of the three classifications are presented in Table 2 . The classification of airflow limitation based on the z-score shows worse discriminative ability than the two classifications based on the percentage of predicted. According to this staging system, patients with COPD with very severe impairment have a longer survival than those with severe airflow limitation.
Using the GOLD classification, a severity-dependent relationship between categories of airflow limitation and total mortality rate was found (Table 3) . Patients with very severe airflow limitation had the worst prognosis, with a risk 10.9 times higher than patients with mild airflow Tables E6-E12 . With the staging system based on z-score, a higher mortality rate in subjects with very severe airflow limitation than in those with severe impairment was only detected in patients with COPD younger than 60 years of age, never smokers, or those with low comorbidity. However, in these patients, the z-score staging system was not able to discriminate differences in mortality rate between moderate and severe airflow limitation. Figure 2 shows the relationship between mortality and percent predicted FEV 1 or z-score FEV 1 expressed as continuous variables. Although the percentage of predicted maintains an inverse exponential relationship with mortality risk, the relationship of z-score with the hazard ratio of death is sigmoidal, so that for small values of FEV 1 , a decrease of z-score is not accompanied by an increase in mortality risk. Therefore, the interpretation of its prognostic value for mortality is more complex, particularly in patients over the age of 60, in whom the sigmoidal morphology of the spline of the hazard ratio of death for z-score is more pronounced (see Figure E1) .
The predictive ability for 5-year survival of post-bronchodilator FEV 1 expressed as predicted percentage or z-score is presented in Figure 3 . Although predictive capacity was significant for both parameters (P , 0.001), the AUCs were higher for predicted percentage than for z-score, showing greater predictive power in both the short-and mid-term (see Figures E2-E7) .
Finally, we established the optimal cutoff for z-score of post-bronchodilator FEV 1 thresholds based on ROC-AUC for total mortality in the dataset (see Figure E8) . With the spline analysis, the highest ROC-AUC values to predict total mortality were obtained by using z-score FEV 1 thresholds of 21.5, 22.5, and 23.5. However, the use of these cutoffs to stratify the severity of airflow limitation did not substantially improve the discriminative capacity for risk of death (see Figure E9 , Table E13 ).
Discussion
To our knowledge, this is the first study focusing on the distribution and prognosis of patients with COPD according to the newly proposed classification of airflow limitation based on post-bronchodilator FEV 1 expressed as z-score. In a large, unselected general population of patients with COPD, we have shown that this staging system has a lower capacity for predicting mortality than classifications based on percentage of predicted values. Unlike other classification schemes of airflow limitation, in the stratification based on z-score, survival is better in the very severe group than in the severe group. Moreover, post-bronchodilator FEV 1 expressed as percentage of predicted value reaches a greater discriminatory power for total 5-year mortality than when it is expressed as z-score, with AUC ranging from 0.714 to 0.760 (% predicted) versus 0.649 to 0.708 (z-score).
The mortality rates in our study were lower than those reported by a pooled analysis of individual patient data from 22 COPD cohorts in the COCOMICS (Collaborative Cohorts to Assess Multicomponent Indices of COPD in Spain) study (19) , reflecting that this is a cohort of outpatients with COPD mainly recruited from general practitioners and not a hospital setting. Moreover, there are notable differences in the characteristics of the selected patients. Although 45% of patients evaluated in the COCOMICS study had severe or very severe airflow limitation (5) , this circumstance only occurred in 27% of our patients. In addition, at least 54% of patients in the COCOMICS study had experienced a severe exacerbation in the previous year (19) , whereas in our cohort only 12.6% had had a moderate or severe exacerbation in the last 12 months. For these reasons, our mortality rates are more similar to those reported by the pooled analysis of patients with COPD recruited from two large population-based studies in the area of Copenhagen (20), despite including a majority of treatment-naive patients (almost 50% of patients with COPD in the most severe categories had not been treated at all).
Today, it is generally accepted that isolated spirometric parameters should not be used as exclusive predictors of prognosis in patients with COPD and that it is necessary to consider other complementary measures (21) (22) (23) (24) . However, the grade of airflow limitation is a constant element in the multidimensional indices, and correct classification of airflow limitation in the moderate to very severe range is relevant in both clinical and research settings (5, 19, 20, 25, 26) .
The main result of our study is the demonstration that the classification of airflow limitation using the z-score of FEV 1 results in a change in the severity degree established by the GOLD classification in up to one-third of patients with COPD. Furthermore, post-bronchodilator FEV 1 has a lower prognostic capacity expressed as z-score than as percentage of the predicted value, both for different cutoffs and continuous variables. A plausible justification might lie in the nature of the z-score calculation. The z-score is a mathematical combination of the percent predicted and between-subject variability to give a single number that accounts for age-and height-related lung function variability expected within comparable healthy individuals. However, the value obtained is very dependent on the between-subject variability, and there is growing evidence showing that the underlying scatter in FEV 1 varies with age (12) . Previously, a disagreement of almost 30% has been described in the classification of mild-moderate versus severe or very severe airflow limitation between the FEV 1% predicted and z-score FEV 1 (13) . The difference between the two grading systems in the estimation of severity is particularly relevant after the age of 60, after which age there is an abrupt fall in the prevalence of severe or very severe impairment when the z-score criterion is used (13) .
In our patients with COPD, evidence was also seen of a dispersion of the z-score versus FEV 1% predicted correlation, mainly for reduced FEV 1 values and in patients older than age 60, which is the age range when COPD is most prevalent (Figure 4) . The comparison of the tables of z-score versus % predicted confirms that after the age of 60 there is a displacement toward the right of the lowest value, in such a way that for a similar value of FEV 1% predicted there is a somewhat more elevated corresponding z-score. This behavior could be interpreted as the adjustment of FEV 1 using its z-score underestimated the severity of the airflow limitation in individuals older than age 60.
Our study has several strengths and limitations. Among the former are the larger number of subjects included and the long follow-up period, including more than 10,000 person-years with a broad spectrum of COPD severity. Second, because of recruitment outside a hospital setting, it is likely that our cohort is highly representative of the general population of patients with COPD. Third, the entire cohort was recruited in the same geographical area, and all clinicians followed the same COPD clinical guidelines for pharmacologic and non-pharmacologic management. Finally, the follow-up information is very accurate, with few participants lost to follow-up.
Several limitations, however, also need to be acknowledged. First, all our participants were white persons with a clear predominance of males, reflecting the epidemiology of COPD in Spain (27) . Therefore, our results should be extrapolated with caution to other populations. Second, despite the considerable sample size, a loss of statistical power in some subanalyses does occur. Third, it was not possible to make an analysis of time-dependent variables to assess changes in medication and other factors. Even in the long-term, our analysis assumed that the patients' condition did not change from baseline, which in some variables may not be so. Finally, we did not compare the airflow limitation classification schemes with multidimensional indices of COPD because this was beyond the scope of this analysis. Figure 4 . Relationship between the z-score for FEV 1 and FEV 1 as percentage of the predicted value in patients with chronic obstructive pulmonary disease aged 60 years or younger (A) and older than 60 years (B). Z-score severity is shown according to the color of the points (black, very severe; red, severe; yellow, moderate; green, mild). The Global Initiative for Chronic Obstructive Lung Disease classification levels for airflow limitation are shown by the horizontal lines.
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In conclusion, our study shows that, in patients with COPD, the classification of airflow limitation based on z-score of post-bronchodilator FEV 1 predicts worse mortality than the staging system based on post-bronchodilator FEV 1 expressed as percentage of predicted (GOLD or ATS/ERS). This phenomenon seems to be caused by the fact that z-score underestimates the severity of airflow limitation in patients older than 60 years of age with severe functional impairment. n
